EUVIMEDEUVIMED entdecken
Crossref

SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase

Augustin Latourte, Sarah Jaulerry, Alice Combier, Chahrazad Cherifi, Yohan Jouan, Thierry Grange, Julien Daligault, Hang-Korng Ea, Martine Cohen-Solal, Eric Hay, Pascal Richette

Annals of the Rheumatic Diseases · 2024

DOI: 10.1136/ard-2024-225645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2024. Verfasst von Augustin Latourte und 10 weiteren Autor:innen. Beteiligte Einrichtung: Inserm UMR-S 1132, Université Paris Cité, Paris, France augustin.latourte@aphp.fr. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular, Serpins, Leukocyte Elastase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Région Ile-de-France, Université de Paris, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Inflammatory mediators such as interleukin 6 (IL-6) are known to activate catabolic responses in chondrocytes during osteoarthritis (OA). This study aimed to investigate the role of a downstream target gene of IL-6, the serine protease inhibitor SerpinA3N, in the development of cartilage damage in OA. METHODS: RNA sequencing was performed in murine primary chondrocytes treated with IL-6, and identified target genes were confirmed in human and murine OA cartilage samples. Male cartilage-specific Serpina3n-deficient mice and control mice underwent meniscectomy (MNX) or sham surgery at 10 weeks of age. Intra-articular injections of SerpinA3N or sivelestat (an inhibitor of leucocyte elastase (LE), a substrate for SerpinA3N) were performed in wild-type mice after MNX. Joint damage was assessed 3-9 weeks after surgery by histology and micro-CT. The effect of sivelestat was assessed in cartilage explants exposed to macrophage-derived conditioned media. RESULTS: RNA sequencing revealed that SerpinA3N is a major target gene of IL-6 in chondrocytes. The expression of SerpinA3N is increased in OA cartilage. Conditional loss of SerpinA3N in chondrocytes aggravated OA in mice, while intra-articular injection of SerpinA3N limited joint damage. Chondrocytes did not produce serine proteases targeted by SerpinA3N. By contrast, macrophages produced LE on IL-6 stimulation. Sivelestat limited the cartilage catabolism induced by conditioned media derived from IL-6-stimulated macrophages. Additionally, an intra-articular injection of sivelestat is protected against OA in the MNX model. CONCLUSIONS: SerpinA3N protects cartilage against catabolic factors produced by macrophages, including LE. SerpinA3N and LE represent new therapeutic targets to dampen cartilage damage in OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisCartilage, ArticularSerpinsLeukocyte ElastaseMaleAnimalsMiceDisease Models, AnimalMeniscectomyChondrocytesSerine Proteinase InhibitorsMacrophagesInjections, IntralesionalInterleukin-6Primary Cell CultureMice, KnockoutMice, Inbred C57BLCells, CulturedAcute-Phase ProteinsGlycineSulfonamides

Stichwörter der Autor:innen

ChondrocytesInflammationOsteoarthritis

Substanzen

SerpinsSerine Proteinase InhibitorsLeukocyte ElastaseInterleukin-6Serpina3n protein, mouseAcute-Phase ProteinssivelestatGlycineSulfonamidesinterleukin-6, mouse

Autor:innen und Institutionen

  • Inserm UMR-S 1132, Université Paris Cité, Paris, France augustin.latourte@aphp.fr.
  • Rheumatology Department, Hôpital Lariboisière APHP.Nord, Paris, France.
  • Inserm UMR-S 1132, Université Paris Cité, Paris, France.
  • Institut Jacques Monod, Université Paris Cité, Paris, Île-de-France, France.

Förderung

  • Région Ile-de-France
  • Université de Paris, Fondation pour la Recherche Médicale

Zitieren

APA

Latourte, A., Jaulerry, S., Combier, A., Cherifi, C., Jouan, Y., Grange, T., Daligault, J., Ea, H. K., Cohen-Solal, M., Hay, E., & Richette, P. (2024). SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2024-225645

Vancouver

Latourte A, Jaulerry S, Combier A, Cherifi C, Jouan Y, Grange T, et al. SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase. Annals of the Rheumatic Diseases. 2024. doi:10.1136/ard-2024-225645

BibTeX
@article{Latourte2024,
  author = {Latourte, Augustin and Jaulerry, Sarah and Combier, Alice and Cherifi, Chahrazad and Jouan, Yohan and Grange, Thierry and Daligault, Julien and Ea, Hang-Korng and Cohen-Solal, Martine and Hay, Eric and Richette, Pascal},
  title = {SerpinA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase},
  journal = {Annals of the Rheumatic Diseases},
  year = {2024},
  doi = {10.1136/ard-2024-225645}
}
Kostenlos starten →